Sino Medical Sciences Technology Balance Sheet Health
Financial Health criteria checks 5/6
Sino Medical Sciences Technology has a total shareholder equity of CN¥898.8M and total debt of CN¥206.2M, which brings its debt-to-equity ratio to 22.9%. Its total assets and total liabilities are CN¥1.3B and CN¥381.2M respectively.
Key information
22.9%
Debt to equity ratio
CN¥206.24m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥224.94m |
| Equity | CN¥898.85m |
| Total liabilities | CN¥381.22m |
| Total assets | CN¥1.28b |
Recent financial health updates
Is Sino Medical Sciences Technology (SHSE:688108) Using Debt Sensibly?
Nov 19
Is Sino Medical Sciences Technology (SHSE:688108) Using Debt In A Risky Way?
Feb 28Recent updates
Is Sino Medical Sciences Technology (SHSE:688108) Using Debt Sensibly?
Nov 19Revenues Tell The Story For Sino Medical Sciences Technology Inc. (SHSE:688108) As Its Stock Soars 25%
Sep 24What Sino Medical Sciences Technology Inc.'s (SHSE:688108) P/S Is Not Telling You
Jun 03Optimistic Investors Push Sino Medical Sciences Technology Inc. (SHSE:688108) Shares Up 26% But Growth Is Lacking
Mar 05Is Sino Medical Sciences Technology (SHSE:688108) Using Debt In A Risky Way?
Feb 28Financial Position Analysis
Short Term Liabilities: 688108's short term assets (CN¥372.6M) exceed its short term liabilities (CN¥156.7M).
Long Term Liabilities: 688108's short term assets (CN¥372.6M) exceed its long term liabilities (CN¥224.5M).
Debt to Equity History and Analysis
Debt Level: 688108 has more cash than its total debt.
Reducing Debt: 688108's debt to equity ratio has increased from 0% to 22.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 688108 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 688108 is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 8.4% per year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 03:09 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sino Medical Sciences Technology Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuo Song | Citic Securities Co., Ltd. |
| Zhuo Huang | Everbright Securities Co. Ltd. |